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Abstract
Introduction:  The  concept  of  quality  of  life  is  subjective  and  variable  deﬁnition,  which  depends
on the  individual’s  perception  of  their  state  of  health.  Quality  of  life  questionnaires  are  instru-
ments designed  to  measure  quality  of  life,  but  most  are  developed  in  a  language  other  than
Portuguese.  Questionnaires  can  identify  the  most  important  symptoms,  focus  on  consultation,
and assist  in  deﬁning  the  goals  of  treatment.  Some  of  these  have  been  validated  for  the
Portuguese  language,  but  none  in  children.
Objective:  To  validate  the  translation  with  cross-cultural  adaptation  and  validation  of  the  Sinus
and Nasal  Quality  of  Life  Survey  (SN-5)  into  Portuguese.
Methods:  Prospective  study  of  children  aged  2--12  years  with  sinonasal  symptoms  of  over
30 days.  The  study  comprised  two  stages:  (I)  translation  and  cross-cultural  adaptation  of  the
SN-5 into  Portuguese  (SN-5p);  and  (II)  validation  of  the  SN5-p.  Statistical  analysis  was  performed
to assess  internal  consistency,  test-retest  reliability,  and  sensitivity,  as  well  as  construct  and
discriminant  validity  and  standardization.
Results:  The  SN-5  was  translated  and  adapted  into  Portuguese  (SN-5p)  and  the  author  of  the
original version  approved  the  process.  Validation  was  carried  out  by  administration  of  the
SN-5p to  51  pediatric  patients  with  sinonasal  complaints  (mean  age,  5.8  ±  2.5  years;  range,
2--12 years).  The  questionnaire  exhibited  adequate  construct  validity  (0.62,  p  <  0.01),  inter-
nal consistency  (Cronbach’s  alpha  =  0.73),  and  discriminant  validity  (p  <  0.01),  as  well  as  good Please cite this article as: Uchoa PR, Bezerra TF, Lima ÉD, Fornazieri MA, Pinna FR, Sperandio FA, et al. Cross-cultural adaptation and
alidation of the Sinus and Nasal Quality of Life Survey (SN-5) into Brazilian Portuguese. Braz J Otorhinolaryngol. 2016;82:636--42.
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test--retest  reproducibility  (Goodman--Kruskal  gamma  =  0.957,  p  <  0.001),  good  correlation  with
a visual  analog  scale  (r  =  0.62,  p  <  0.01),  and  sensitivity  to  change.
Conclusion:  This  study  reports  the  successful  translation  and  cross-cultural  adaptation  of  the
SN-5 instrument  into  Brazilian  Portuguese.  The  translated  version  exhibited  adequate  psycho-
metric properties  for  assessment  of  disease-speciﬁc  quality  of  life  in  pediatric  patients  with
sinonasal  complaints.
©  2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published  by
Elsevier Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Saúde  da  crianc¸a
Adaptac¸ão  e  validac¸ão  transcultural  da  Sinus  and  Nasal  Quality  of  Life  Survey  (SN-5)
para  o  português  brasileiro
Resumo
Introduc¸ão:  O  conceito  de  qualidade  de  vida  é  subjetivo  e  de  deﬁnic¸ão  variável;  depende  da
percepc¸ão do  indivíduo  quanto  ao  seu  estado  de  saúde.  Os  questionários  para  qualidade  de  vida
são instrumentos  planejados  para  medir  a  qualidade  de  vida,  mas  a  maioria  foi  desenvolvida
em línguas  diferentes  do  português.  Os  questionários  podem  identiﬁcar  os  sintomas  mais  impor-
tantes, serem  focadas  na  consulta  e  ajudar  na  deﬁnic¸ão  das  metas  terapêuticas.  Alguns  desses
instrumentos  foram  validados  para  o  idioma  português,  mas  nenhum  em  crianc¸as.
Objetivo:  Validar  a  traduc¸ão  com  adaptac¸ão  transcultural  e  validac¸ão  do  questionário  SN-5  para
o idioma  português.
Método:  Estudo  prospectivo  de  crianc¸as  com  idades  entre  2  e  12  anos  com  sintomas  sinonasais
com mais  de  30  dias  de  durac¸ão.  O  estudo  consistiu  em  dois  estágios:  (I)  traduc¸ão  e  adaptac¸ão
transcultural  do  SN-5  para  o  idioma  português  (SN-5p);  e  (II)  validac¸ão  do  SN5-p.  Foi  real-
izada análise  estatística  para  avaliac¸ão  da  consistência  interna,  conﬁabilidade  de  reteste  e
sensibilidade,  bem  como  construto  e  validade  discriminante  e  de  padronizac¸ão.
Resultados:  O  questionário  SN-5  foi  traduzido  e  adaptado  para  o  idioma  português  (SN-5p)  e
o autor  da  versão  original  aprovou  o  processo.  A  validac¸ão  foi  realizada  pela  administrac¸ão
do SN-5p  a  51  pacientes  pediátricos  com  queixas  sinonasais  (media  de  idade,  5,8  ±  2,5  anos;
variac¸ão de  2--12  anos).  O  questionário  exibiu  validade  de  construto  adequada  (0,62,  p  <  0,01),
consistência  interna  (alfa  de  Cronbach  =  0,73)  e  validade  discriminante  (p  <  0,01),  além  de
boa reprodutibilidade  de  teste-reteste  (gama  de  Goodman--Kruskal  =  0,957,  p  <  0,001),  boa
correlac¸ão com  uma  escala  analógica  visual  (r  =  0,62,  p  <  0,01)  e  sensibilidade  à  mudanc¸a.
Conclusão:  O  presente  estudo  relata  uma  bem-sucedida  traduc¸ão  e  adaptac¸ão  transcultural  do
questionário  SN-5  para  o  idioma  português  brasileiro.  A  versão  traduzida  exibiu  propriedades  psi-
cométricas  adequadas  para  avaliac¸ão  da  qualidade  de  vida  especíﬁca  para  doenc¸as  em  pacientes
pediátricos  com  queixas  sinonasais.
©  2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Este e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://
ses/
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Introduction
The  concept  of  quality  of  life  is  subjective  and,  therefore,
variously  deﬁned.  It  is  related  to  the  individual’s  percep-
tion  of  his  or  her  health  status  in  the  major  domains  or
dimensions  of  life.1,2
The  main  instruments  used  in  assessment  of  quality  of
life  are  quality  of  life  questionnaires.  These  instruments  are
intended  to  assess  the  various  aspects  and  dimensions  of  a
patient’s  life,  including  physical,  psychological,  social,  role
performance,  pain,  and  sleep  quality,  in  addition  to  speciﬁc
symptoms.1--6
Sinonasal  symptoms  and  their  correlative  diseases,  such
as  rhinitis  and  rhinosinusitis,  account  for  a  signiﬁcant  portion
of  visits  to  health  care  facilities.  Rhinitis  is  estimated  to
affect  approximately  500  million  people  worldwide.7 The
o
dby-nc-nd/4.0/).
nternational  Study  of  Asthma  and  Allergies  in  Childhood
ISAAC)  revealed  an  upward  trend  for  rhinitis  prevalence  in
razilian  children,  with  rates  increasing  from  10.3%  to  17.4%
mong  6--7  year-olds  and  from  8.9%  to  28.5%  among  13  to
4  year-olds  between  1996  and  2002.8 Rhinosinusitis  affects
pproximately  31  million  people  every  year  in  the  United
tates  alone,  generating  an  annual  cost  of  US$6  million,  and
s  one  of  the  leading  causes  of  antibiotic  prescription  and  of
bsenteeism.9--11 Its  prevalence  is  estimated  at  14%  in  adults
nd  7.6%  in  the  pediatric  population.12 Nationwide  data  are
nly  available  for  the  adult  Brazilian  population.  Prevalence
s  estimated  at  5.5%  according  to  household  surveys  con-
ucted  in  São  Paulo.13Several  disease-speciﬁc  questionnaires  have  been  devel-
ped  to  characterize  morbidity  in  patients  with  sinonasal
isease,  such  as  the  Rhinitis  Quality  of  Life  Questionnaire14
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nd  the  Sino-Nasal  Outcome  Test-20  and  -22  (SNOT-20  and
22).15 The  Sinus  and  Nasal  Quality  of  Life  Survey  (SN-5)  was
he  ﬁrst  validated  questionnaire  for  assessment  of  disease-
peciﬁc  quality  of  life  related  to  sinonasal  symptoms  in
ediatric  populations.16 The  SN-5  is  a  short,  straightforward,
nd  easily  administered  instrument.  Since  its  validation,  it
as  been  employed  in  epidemiological  studies17 and,  partic-
larly,  in  trials  of  clinical18 and  surgical19,20 interventions.
ethods
his  prospective,  observational  study  was  conducted  at  a
ospital,  between  October  2013  and  June  2014.  Participa-
ion  was  voluntary,  and  all  patients  and  their  legal  guardians
rovided  written  informed  assent  and  consent  respectively,
s  approved  by  the  local  research  ethics  committee  (CAAE:
5955813.6.0000.5201).
uestionnaire
he  SN-5  consists  of  a  series  of  ﬁve  questions  to  be  answered
y  the  patient’s  parents.  Each  item  is  scored  on  a seven-
oint  scale  designed  to  assess  symptom  frequency  during  the
receding  four  weeks.  The  items  assess  symptoms  related
o:  (a)  nasal  obstruction;  (b)  sinus  infection;  (c)  allergy
ymptoms;  (d)  emotional  distress;  and  (e)  activity  limita-
ions.  At  the  end  of  the  questionnaire,  overall  quality  of  life
as  assessed  by  means  of  a  visual  analog  scale  (VAS)  from  0
o  10.16
ecruitment
he  parents  of  children  seen  at  the  outpatient  otorhin-
laryngology  clinic  who  met  the  inclusion  criteria  were
nvited  to  take  part  voluntarily.  The  inclusion  criteria  were:
a)  child  aged  2--12  years;  (b)  presence  of  one  or  more
f  the  following  symptoms  for  at  least  one  month  at  the
ime  of  assessment:  rhinorrhea  or  postnasal  drip,  nasal
ongestion,  nasal  obstruction,  daytime  cough,  and  halito-
is;  and  (c)  caregiver  ability  to  read  and  understand  the
ortuguese  language.  The  exclusion  criteria  were:  (a)  pri-
ary  diagnosis  of  obstructive  sleep  apnea  syndrome  (OSAS)
aused  by  tonsillar  hyperplasia;  (b)  developmental  delay
r  cognitive  impairment  and/or  craniofacial  abnormalities;
c)  secondary  chronic  rhinosinusitis:  fungus  ball,  invasive
ungal  disease,  granulomatous  diseases,  vasculitides,  iso-
ated  mucocele,  malignant  or  benign  sinonasal  tumors,
ongenital  abnormalities  (e.g., primary  ciliary  dyskinesia,
ystic  ﬁbrosis),  and  oroantral  ﬁstula;  and  (d)  primary  or
econdary  immune  deﬁciency.
ross-cultural  adaptationross-cultural  adaptation  of  the  original,  English-language
N-5  (Fig.  1)  into  Portuguese  (Fig.  2)  followed  a  standard-
zed  process.21 The  intermediate  and  ﬁnal  versions  resulting
rom  this  process  were  sent  to  the  author  of  the  original
nstrument  to  ensure  that  the  original  meaning  of  the  items
as  preserved.
ﬁ
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alidation  of  the  SN-5p
he  Portuguese  version  of  the  instrument  was  administered
t  three  time  points,  as  in  the  original  study:  in  person,  at
he  initial  patient  encounter;  by  telephone,  one  week  later;
nd  again  in  person  after  four  weeks.  Test--retest  reliabil-
ty  was  assessed  by  means  of  the  Goodman--Kruskal  gamma
oefﬁcient  ()  between  the  results  of  the  initial  encounter
nd  the  one-week  time  points.
tatistical  analysis
he  minimum  sample  size  was  estimated  at  45  patients,  with
 correlation  coefﬁcient  of  0.20  as  the  outcome  of  inter-
st.  An  alpha  value  of  5%  (p  <  0.05)  was  deemed  signiﬁcant
or  all  statistical  tests.16 Analyses  were  performed  in  PASW
tatistics  v.  18  (Chicago,  IL,  United  States).
Internal  consistency  reliability  was  estimated  by  calcu-
ation  of  Cronbach’s  alpha  and  inter-item  and  item-total
orrelations,  and  was  considered  acceptable  if  >0.70.
Test--retest  reliability  of  the  SN-5  questionnaire  was
ssessed  by  means  of  Spearman’s  correlation  coefﬁcient,
omparing  responses  to  the  initial  questionnaire  to  the
esponses  of  patients  who  did  not  exhibit  any  change  in
verall  quality  of  life  score  as  assessed  on  the  VAS.
Discriminant  validity  was  assessed  by  means  of  the  dif-
erence  in  SN-5  scores  between  two  groups:  patients  in  the
tudy  group  and  25  patients  seen  at  the  study  clinic  for  other
easons  and  with  no  sinonasal  complaints  (control  group).
he  Mann--Whitney  U  test  was  used  for  this  comparison.
The  sensitivity  to  change  of  the  instrument  was  assessed
y  calculation  of  the  mean  effect  size.6
esults
he  Portuguese  version  of  the  SN-5  (SN-5p)  was  administered
o  a  group  of  patients  with  sinonasal  complaints  between
ctober  2013  and  June  2014.  Overall,  51  participants  met
he  inclusion  criteria,  of  whom  28  (54.9%)  were  male  and  23
45.1%)  were  female.  The  mean  age  was  5.82  ±  2.51  years
range,  2--12  years).
The  SN-5p  was  administered  to  the  selected  patients  and,
fter  assessment  of  applicability,  was  not  found  to  require
odiﬁcation  of  any  items.
The  internal  consistency  of  the  SN-5p,  as  measured  by
ronbach’s  alpha,  was  0.73  (total  scale).  Item-item  and
tem-total  correlation  analysis  showed  adequate  construct
alidity.
Discriminant  validity  was  statistically  signiﬁcant  (median
interquartile  range])  =  0.20  [0.20]  vs.  3.40  [1.80],  U  =  752.5,
 < 0.01;  Fig.  3).  Test--retest  reproducibility  one  week  after
nitial  interview  was  adequate  (  =  0.957,  p  <  0.001).  Sig-
iﬁcant  correlation  was  observed  between  the  VAS  and
he  SN-5p,  as  assessed  by  Spearman’s  coefﬁcient  (r  = 0.62,
 < 0.01)  (Fig.  4).  The  effect  size  was  2.03.
Table  1  shows  the  change  in  SN-5  scores  between  the
rst  encounter  and  the  last  time  point  of  assessment
four  weeks  later).  Signiﬁcant  improvement  in  all  symptoms
as  observed  after  administration  of  proposed  treatments
p  <  0.001),  which  indicates  that  the  SN-5  is  able  to  measure
linical  improvement.
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Figure  1  Questionnaire  E
Table  1  Median  and  interquartile  range  sinonasal  com-
plaint  scores  on  initial  and  ﬁnal  assessment.
Complaint  Initial  Final  Change  p
Sinus  infection  5  (3)  2  (3)  −2  (1)  <0.001
Nasal obstruction  6  (6)  1  (0)  −3  (5)  <0.001
Allergy symptoms  4  (3)  1  (2)  −2  (3)  <0.001
Emotional  distress  3  (2)  1  (1)  −2  (1)  <0.001
Activity  limitations  2  (2)  1  (1)  0  (1)  <0.001
VAS 6 (3)  9  (2)  3  (2)  <0.001
SN-5 3.4  (2) 1.8  (1)  −1.6  (2)  <0.001
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24VAS, visual analog scale; SN-5, Sinus and Nasal Quality of Life
Survey.
Discussion
Assessment  of  quality  of  life  in  pediatric  patients  usually
poses  a  challenge.  Those  who  should  be  the  most  reliable
informants  --  patients  themselves  --  may  be  unable  to  express
their  perceptions  of  quality  of  life  as  clearly  as  adults  can.
Parents  have  their  own  perceptions  of  their  children’s  qual-
ity  of  life,  but  from  a  standpoint  that  may  be  biased  by  their
own  experiences,  by  the  concern  they  wish  to  convey  to
w
l
english-language  SN-5.
he  clinician,  and  by  their  affectional  bonds  with  the  child.
hese  facts  clearly  demonstrate  the  unique  challenges  of
uality  of  life  assessment  in  pediatric  patients  and  the  need
o  raise  awareness  of  the  translation,  cross-cultural  adap-
ation,  and  validation  of  the  SN-5  instrument  in  Portuguese
Fig.  2).
Several  questionnaires  exist  for  the  assessment  of  overall
uality  of  life  in  pediatric  patients,  such  as  the  Autoques-
ionnaire  de  Qualité  de  Vie  Enfant  Imagé  (AUQEI),22 but
hese  instruments  do  not  provide  precise  information  as
ompared  with  questionnaires  containing  items  designed  to
ssess  a  speciﬁc  disease.  One  of  the  ﬁrst  pediatric  health-
elated  quality  of  life  (HRQoL)  questionnaires  was  the  TNO
ZL  Child  Quality  Of  Life  (TACQOL)  questionnaire,  devel-
ped  in  1992.  Thus  far,  few  attempts  had  been  made  to
evelop  instruments  speciﬁcally  for  the  assessment  of  pedi-
tric  patients.23
One  of  the  ﬁrst  such  publications  in  the  ﬁeld  of  otorhin-
laryngology  was  a  1998  French  questionnaire  devised  to
ssess  the  cumulative  effect  of  recurrent  child  ear,  nose,
nd  throat  infections  on  parents’  quality  of  life  during  the
inter  season.
It  has  been  demonstrated  that  deterioration  of  quality  of
ife  in  patients  with  sinonasal  complaints  can  lead  to  sev-
ral  disturbances,  including  impairment  of  the  activities  of
640  Uchoa  PR  et  al.
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aily  living  and  issues  at  work  and  at  school,  particularly  in
atients  with  symptoms  classiﬁed  as  moderate  to  severe.7
he  patient’s  involvement  in  the  proposed  treatment  and
he  need  for  a  broader  assessment  of  how  and  to  which
xtent  a  given  disease  or  medical  intervention  affects  qual-
ty  of  life  are  essential  factors  in  any  healthcare  setting.1
easurement  of  quality  of  life  can  help  screen  and  monitor
atients  with  altered  clinical  status,  demonstrate  popula-
ion  perceptions  of  different  health  problems,  and  measure
he  outcomes  of  medical  interventions.1
Sinonasal  complaints  and  their  correlative  diseases,
uch  as  rhinitis  and  rhinosinusitis,  account  for  a  signiﬁcant
ortion  of  visits  to  health  care  facilities.  Patients  with  these
a
o
M
Etuguese-language  SN-5.
omplaints  can  present  with  symptoms  such  as  sneezing,
asal  discharge,  itching,  nasal  obstruction,  facial  pain,  and
oughing,  as  well  as  fatigue,  mood  disorders,  and  cognitive
isturbances.
The  need  for  a  disease-speciﬁc  quality  of  life  question-
aire  to  assess  the  impact  of  sinonasal  symptoms  in  children
as  been  met  by  the  development  and  validation  of  the  SN-5
nstrument.  The  SN-5  was  selected  for  translation  because
t  is  easily  and  quickly  administered.16 The  cross-cultural
daptation  process  is  essential  in  that  it  ensures  that  the
verall  meaning  of  the  original  instrument  is  preserved.
ost  questionnaires  are  developed  and  validated  in  the
nglish  language.25 A  poor  translation  can  produce  an
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bFigure  4  Scatter  plot.  VAS,  visual  analog  scale;  SN-5,  Sinus
and Nasal  Quality  of  Life  Survey.
instrument  that  is  not  equivalent  to  the  original,  and  this
lack  of  equivalence  limits  comparison  of  responses  obtained
in  different  populations.  The  process  of  cross-cultural
adaptation  of  the  SN-5  employed  a  detailed,  systematic
procedure  for  formal  assessment  of  semantic  equivalence,
as  published  elsewhere.21
After  its  development,  the  SN-5p  underwent  a  series  of
semantic  validation  procedures,  which  are  important  and
necessary  as  a  means  of  ensuring  conceptual  equivalence
with  the  original  instrument.  The  overall  impression  of  the
SN-5p  was  positive,  conﬁrming  the  relevance  of  its  items
to  assessment  of  quality  of  life  in  pediatric  patients,  its
proper  understanding,  and  the  adequacy  of  the  item  scoring
scale.
The  internal  consistency  reliability  of  the  total  scale,  as
measured  by  Cronbach’s  alpha  coefﬁcient,  was  adequate
(0.76).  Cronbach’s  alpha  is  an  important  measure  because
it  assesses  the  extent  to  which  questionnaire  items  corre-
late  among  themselves  and  with  the  overall  results  of  the
C
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tudy;  it  usually  represents  a  measure  of  item  reliability.
he  original,  English-language  version  of  the  instrument16
ad  a  Cronbach’s  alpha  of  0.62.  Therefore,  the  coefﬁcient
btained  for  the  Portuguese  version  suggests  good  reliability
nd  shows  that  the  several  questionnaire  items  designed  to
easure  the  same  construct  yielded  similar  results,  which
s  a  ﬁnding  relevant  to  the  applicability  of  the  instru-
ent.
The  SN-5p  exhibited  test-retest  reliability,  with  a
oodman--Kruskal  gamma  of  0.957  (p  <  0.001).  This  statis-
ic  suggests  good  reproducibility  of  the  questionnaire  when
t  was  re-administered  to  patients  one  week  after  the  ﬁrst
ncounter.
When  the  SN-5p  is  administered  to  the  same  individual
epeatedly  over  time,  changes  in  score  usually  provide  indi-
ect  estimates  of  an  overall  change  in  quality  of  life,  with
irect  estimates  of  clinical  change  reported  by  the  caregiver.
ranslation  and  validation  of  the  SN-5p  provides  clinicians
nd  investigators  with  a  useful,  user-friendly  instrument
hat  meets  a  pressing  need  in  view  of  the  high  prevalence
f  sinonasal  complaints  in  the  pediatric  population.  Indi-
ect  changes  in  health  status  can  be  measured  as  changes
n  score,  as  obtained  through  completion  of  the  instru-
ent  after  an  intervention,  and  this  can  be  used  clinically
o  evaluate  the  quality  of  life  of  pediatric  patients  with
inonasal  disease.  The  size  of  the  change  in  score  reﬂects
he  degree  of  change  in  quality  of  life  experienced  by  the
ndividual.
Total  SN-5p  scores  also  correlated  well  with  VAS  scores,
ith  a  coefﬁcient  of  0.62  (p  <  0.001).  This  demonstrates  the
xtent  to  which  VAS  scores  correspond  to  the  overall  clinical
icture  of  the  patient  and  that  questionnaire  items  are  in
act  consistent  with  the  phenomena  of  interest,  providing
vidence  of  the  reliability  of  the  questionnaire.
Analysis  of  discriminant  validity  between  the  control  and
atient  groups  (median  [interquartile  range]  =  0.20  [0.20]  vs.
.40,  U  =  752.5,  p  <  0.01)  demonstrated  good  ability  of  the
uestionnaire  to  discriminate  between  individuals  with  and
ithout  sinonasal  symptoms.
Effect  sizes  revealed  that  the  instrument  was  sensitive
o  change,  as  demonstrated  by  the  ratio  of  mean  scores  and
heir  standard  deviations.  The  effect  size  of  2.02  suggests
dequate  sensitivity  to  longitudinal  changes.
The  overall  impression  of  the  SN-5p  was  positive,  con-
rming  the  relevance  of  its  items  to  assessment  of  quality
f  life  in  pediatric  patients,  its  proper  understanding,  and
he  adequacy  of  the  item  scoring  scale.
onclusion
he  SN-5p  was  successfully  translated  and  cross-culturally
dapted  into  Brazilian  Portuguese,  and  the  translated  ver-
ion  exhibited  adequate  properties.  The  questionnaire  was
ffective  in  assessing  the  quality  of  life  of  pediatric  patients
ith  sinonasal  complaints,  and  can  be  used  for  this  purpose
oth  in  the  clinical  setting  and  in  future  research.onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
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